
zzso neuroendocrine tumors are zzso The most dramatic advances have been in the application of molecular genetic techniques to define the affected genes and to develop zzso testing for patients with multiple zzso zzso zzso zzso zzso at specific zzso of the zzso zzso have been demonstrated in patients with multiple zzso zzso types zzso zzso and familial zzso zzso zzso not associated with multiple zzso zzso This has led to direct DNA testing for these zzso in patients at risk for these zzso The approach to zzso testing, diagnosis, and early treatment of these patients is discussed as a model for the approach to zzso zzso zzso testing with DNA markers is still required for patients with multiple zzso zzso type I because the responsible gene has not yet been zzso Efforts to clarify the zzso of other familial neuroendocrine tumors not associated with multiple zzso zzso zzso zzso zzso zzso and zzso also are zzso The use of molecular genetic techniques as a powerful tool for the early identification and treatment of susceptible individuals is zzso 

